AX PHARMACEUTICAL CORP- avanafil powder

Země: Spojené státy

Jazyk: angličtina

Zdroj: NLM (National Library of Medicine)

Aktivní složka:

AVANAFIL (UNII: DR5S136IVO) (AVANAFIL - UNII:DR5S136IVO)

Dostupné s:

AX Pharmaceutical Corp

Podání:

NOT APPLICABLE

Stav Autorizace:

Bulk Ingredient For Animal Drug Compounding

Charakteristika produktu

AX PHARMACEUTICAL CORP- AVANAFIL POWDER
AX PHARMACEUTICAL CORP
----------
AX PHARMACEUTICAL CORP
avanafil powder
AX Pharmaceutical Corp
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 2157-6 21
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
AVANAFIL (UNII: DR5S136 IVO) (AVANAFIL - UNII:DR5S136 IVO)
AVANAFIL
49 .5 g in 50 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
WATER (UNII: 0 59 QF0 KO0 R)
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 2157-6 21-0 1
50 g in 1 JAR
0 7/24/20 18
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
bulk ingredient fo r animal drug
c o mpo unding
0 7/24/20 18
LABELER -
AX Pharmaceutical Corp (202924858)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
AX Pharmaceutical Co rp
20 29 248 58
repack(6 2157-6 21) , relabel(6 2157-6 21)
Revised: 7/2018